Our Hemostasis reagent portfolio has been carefully selected to ensure our customers receive the highest quality performance from our market leading analyzers. Our reagent portfolio offers flexibility of vial sizes and provides superb on-board stability across our Hemostasis analyzers.
In 2010, Sysmex Corporation aquired HYPHEN BioMed enabling us to provide a comprehensive line of reagents to complement our existing Siemens hemostasis reagents portfolio. HYPHEN BioMed is a scientific company with experience in the field of thrombosis, hemostasis and auto-immunity, producing a full line of diagnostic and research reagents, distributed worldwide.
Please contact your respective Sysmex representative for other Hyphen diagnostic and research products